Abstract:It has been well known that WT1 gene is overexpressed in leukemia cells regardless subtypes comparing to normal hematopoietic cells. The precise effect of WT1, whether an oncogenic or tumor suppressive effect, in leukemogenesis remains controversial. Isoforms of WT1 protein products caused by alternative splicing may exert different biological function. To investigate the role of WT1 product composed of four major isoforms in certain ratios in hematopoietic cells, we have established a leukemia cell line NB4 which stably expressed exogenous WT1 gene isoforms, then studied their effects on cell biologic behaviors including proliferation, apoptosis and differentiation and its possible molecular mechanisms. The eukaryotic expression recombinant vectors (pCB6+/WT1) containing 4 clones of full-length human WT1 isoforms (WTA: −17aa/-KTS, WTB:+17aa/-KTS, WTC: −17aa/+KTS, WTD: +17aa/+KTS) cDNA were transduced into the leukemia cell line NB4 by electroporation.The positive stable cell clones (NB4/WT1) were obtained. The integration and expresion of WT1 gene isoforms in NB4 cells were confirmed by PCR. RT-PCR and western blotting. We then mainly concentrated on the effect of WT1 isoform WTA (−17aa/-KTS) since this transgene will markedly change the WT1 isoform ratio in NB4 cells from +17aa/+KTS dominant to −17aa/-KTS dominant. The proliferation ability was measured by trypan blue exclusion assay, MTT assay, colony forming assay and cell cycles analysis. Morphology, NBT reduction and CD11b expression were examined to access the cell differentiation. AnnexinV binding tested by FCM and agarose gel electrophoresis were performed to access the susceptibility to action of apoptosis inducing agents. Expressions of PML/RARα, RbAP46, P21, P53, Bcl-2, Bcl-XL and C-myc genes in NB4/WTA cells were determined by semi-quantitative RT-PCR DNA microarray was used to explore the alteration of gene expression profiles in NB4/WTA cells. The proliferation rate of NB4/WTA significantly decreased as measured by growth curves and colony forming ability, while the NB4/WTA cells arrested in S stage increased. NB4/WTA cells treated with ATRA 0.5μM for 2 days were induce to partially differentiate compared to a much higher morphological differentiation rate and CD11b expression level in the negative control cells in same condition. After exposure to As2O3 at 0.8μM for 48 hours, the NB4/WTA cells,but not the control cells, exhibited features of apoptosis RT-PCR have showed increasing level of PML/RARα, RbAP46, P21 and C-myc gene expression, a decreased level of Bcl-2 and a relative constant expression of P53,Bcl-XL, VEGF, CyclinD1 and CyclinD2 in NB4/WTA cells. The gene expression profiles were found changed in transfected NB4 cells. 89 of 4096(2.17%) genes were found to have a differential expression pattern, most of which (nearly 88.7%) were down-regulated. Our results indicated that overexpression of exogenous WT1 isoform (−17aa/-KTS) gene inhibited the proliferation of leukemia cells by delaying the progression of S into G2/M stage in cell cycle and inducing cell apoptosis by down-regulating the Bcl-2 gene expression. WTA gene could also partially inhibit the differentiation of NB4 cells. The introduction and expression of exogenous WT1 isoform gene can change the gene expression profiles in NB4 cells, leading to inhibition of cell growth, retardation of differentiation and more sensitive to apoptosis inducing agents.

Detection of WT1 Gene Isoform Expression During Induction of Differentiation of NB4 Cell Line

Changes of the Expression Level of WT1, RbAp46, and IGFBP-rP1 Genes During the Differentiation of NB4 Cell Line

The Effect of WT1 Expression on the Prognosis of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia

[The influence of different WT1 gene isoforms expression pattern on the differentiation of leukemia cell line NB4].

Changes in Expression of WT1 Isoforms During Induced Differentiation of the NB4 Cell Line.

Study on the Biological Functions of WT1 Gene Isoforms in Leukemia Cells.

Effects of WT1 gene isoform transfection on gene expression profiles in leukemia cell line NB4

Inhibitory Effect of WT1 Gene Isoform Transfection on Proliferation of Leukemia Cell Line NB4

Expression pattern of Wilms' tumor gene WT1 (17AA+) isoform in leukemia

Detection of Wt1 Expression in Bone Marrow Cells of Acute Leukemia Patients and During Their Follow-Up after Allo-Bmt Using Real-Time Quantitative Rt-Pcr.

Detection of WT1 Gene by Real-Time Quantitative PCR in Childhood Leukemia

Experimental Study on Apoptosis of Leukemia Cell Line NB4 Transfected with WT1 Gene

Expressions of Wilms Tumor Gene 1 and Isoform WT1(17AA+) in Children with Acute Myeloid Leukemia and Their Clinical Significance

[Detection of WT1 Expression in Bone Marrow of Acute Leukemia Patients with Real-Time Quantitative RT-PCR].

Detection of WT1 gene in acute myeloid leukemia children by real-time fluorescent quantitative RT-PCR and its clinical significance]

WT1 gene expression difference in leukemia and non-leukemia and its clinical significance]

High Expression Of Wt1 Gene In Acute Myeloid Leukemias With More Predominant Wt1+17aa Isoforms At Relapse

Clinical Significance of Real - Time Fluorescent Quantitative PCR for Detection of WT1 Gene Expression in Leukemia Patients

Significance of Dynamic Detection of WT1 Expression on Monitoring Minimal Residual Disease in Leukemia Patients Following Allogeneic Bone Marrow Transplantation

Transfection of WT1 gene isoforms and establishment of leukemia cell lines stably overexpressing WT1 gene

[Expression of WT1 Gene in Children with Acute Myeloid Leukemia].